Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis

S Shao, C Chen, G Shi, Y Zhou, Y Wei, N Fan… - Pharmacology & …, 2021 - Elsevier
Inflammasomes are multi-protein macromolecular complexes that typically comprise of three
units, a sensor, an adaptor and procaspase-1. The assembly of each inflammasome is …

Microglial NLRP3 inflammasome activation in multiple sclerosis

M Olcum, B Tastan, C Kiser, S Genc, K Genc - Advances in protein …, 2020 - Elsevier
Multiple sclerosis (MS) is a chronic, autoimmune and neuroinflammatory disease of the
central nervous system (CNS) mediated by autoreactive T cells directed against myelin …

Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

DW Kim, KJ Tu, A Wei, AJ Lau, A Gonzalez-Gil… - Molecular …, 2022 - Springer
Background Amongst risk alleles associated with late-onset Alzheimer's disease (AD), those
that converged on the regulation of microglia activity have emerged as central to disease …

Interferon-β plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration

JP Barrett, RJ Henry, KA Shirey, SJ Doran… - Journal of …, 2020 - Soc Neuroscience
DNA damage and type I interferons (IFNs) contribute to inflammatory responses after
traumatic brain injury (TBI). TBI-induced activation of microglia and peripherally-derived …

Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering …

ZZ Al-Ghezi, PB Busbee, H Alghetaa… - Brain, behavior, and …, 2019 - Elsevier
Currently, a combination of marijuana cannabinoids including delta-9-tetrahydrocannabinol
(THC) and cannabidiol (CBD) is used as a drug to treat muscle spasticity in patients with …

[HTML][HTML] Therapeutic targeting of STING-TBK1-IRF3 signalling ameliorates chronic stress induced depression-like behaviours by modulating neuroinflammation and …

N Duan, Y Zhang, S Tan, J Sun, M Ye, H Gao… - Neurobiology of …, 2022 - Elsevier
Stress is well known to contribute to the development of both neurological and psychiatric
diseases. In the central nervous system, a role for STING (stimulator of interferon genes) in …

Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective …

LF González, E Acuña, G Arellano, P Morales… - Journal of Controlled …, 2021 - Elsevier
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system
(CNS). Interferon (IFN)-β constitutes one of the first-line therapies to treat MS, but has limited …

Regulation of microglia polarization after cerebral ischemia

H Wang, J Li, H Zhang, M Wang, L Xiao… - Frontiers in Cellular …, 2023 - frontiersin.org
Stroke ranks second as a leading cause of death and permanent disability globally.
Microglia, innate immune cells in the brain, respond rapidly to ischemic injury, triggering a …

Interferons and multiple sclerosis: Lessons from 25 years of clinical and real-world experience with intramuscular interferon beta-1a (Avonex)

SL Cohan, BA Hendin, AT Reder, K Smoot, R Avila… - CNS drugs, 2021 - Springer
Abstract Recombinant interferon (IFN) β-1b was approved by the US Food and Drug
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …

B cells in neuroinflammation: new perspectives and mechanistic insights

JJ Ahn, M Abu-Rub, RH Miller - Cells, 2021 - mdpi.com
In recent years, the role of B cells in neurological disorders has substantially expanded our
perspectives on mechanisms of neuroinflammation. The success of B cell-depleting …